caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1174732663

Gopal Narasimhan

Internal MedicineNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$1K
Payment records
11
By payment type
Compensation for serving as faculty or as a speaker for a medical education program$950
Food and Beverage$199
REFERRAL NETWORK

Where Gopal Narasimhan's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 5 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
2760
Empire City Laboratories, Inc
Clinical Laboratory · Brooklyn, NY
2263
Richard Jung
Anesthesiology · Burlingame, CA
1838
THE NEW YORK AND PRESBYTERIAN HOSPITAL1121
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
Gpddc, Llc
Ambulatory Surgical Center · New York, NY
2757
Theranostix Inc
Clinical Laboratory · Beltsville, MD
2456
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
2144
THE NEW YORK AND PRESBYTERIAN HOSPITAL1327
Richard Jung
Anesthesiology · Burlingame, CA
1112
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
4,981
Beneficiaries
—
Total drug cost
$1.1M
Distinct drugs
34
Brand share
46.5%
Top prescribed drugs
Pantoprazole Sodium802 claims
Dicyclomine Hcl611 claims
Linaclotide574 claims
Omeprazole485 claims
Dexlansoprazole447 claims